191 related articles for article (PubMed ID: 9166292)
21. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
23. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
24. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
Gerharz CD; Ramp U; Déjosez M; Mahotka C; Czarnotta B; Bretschneider U; Lorenz I; Müller M; Krammer PH; Gabbert HE
Lab Invest; 1999 Dec; 79(12):1521-34. PubMed ID: 10616203
[TBL] [Abstract][Full Text] [Related]
25. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
[TBL] [Abstract][Full Text] [Related]
27. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
29. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
32. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
33. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
34. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
36. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
[TBL] [Abstract][Full Text] [Related]
37. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
38. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]